These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 18487994

  • 21. Large duct type invasive adenocarcinoma of the pancreas with microcystic and papillary patterns: a potential microscopic mimic of non-invasive ductal neoplasia.
    Bagci P, Andea AA, Basturk O, Jang KT, Erbarut I, Adsay V.
    Mod Pathol; 2012 Mar; 25(3):439-48. PubMed ID: 22056954
    [Abstract] [Full Text] [Related]

  • 22. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S, Schirren M, Klauss M, Bergmann F, Hackert T, Hartwig W, Strobel O, Grenacher L, Büchler MW, Werner J.
    Surgery; 2012 Sep; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
    [Abstract] [Full Text] [Related]

  • 23. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.
    Furukawa T, Klöppel G, Volkan Adsay N, Albores-Saavedra J, Fukushima N, Horii A, Hruban RH, Kato Y, Klimstra DS, Longnecker DS, Lüttges J, Offerhaus GJ, Shimizu M, Sunamura M, Suriawinata A, Takaori K, Yonezawa S.
    Virchows Arch; 2005 Nov; 447(5):794-9. PubMed ID: 16088402
    [Abstract] [Full Text] [Related]

  • 24. Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.
    Tsukahara M, Nagai H, Kamiakito T, Kawata H, Takayashiki N, Saito K, Tanaka A.
    Pathol Int; 2005 Feb; 55(2):63-9. PubMed ID: 15693851
    [Abstract] [Full Text] [Related]

  • 25. Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma.
    Takeshita A, Kimura W, Hirai I, Takasu N, Moriya T, Tezuka K, Watanabe T.
    Pancreas; 2012 Jan; 41(1):114-20. PubMed ID: 22143341
    [Abstract] [Full Text] [Related]

  • 26. Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma.
    Goh BK.
    Surgery; 2007 Apr; 141(4):545-6. PubMed ID: 17383536
    [No Abstract] [Full Text] [Related]

  • 27. Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma.
    Murakami Y, Uemura K, Ohge H, Hayashidani Y, Sudo T, Sueda T.
    Surgery; 2006 Sep; 140(3):448-53. PubMed ID: 16934608
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients.
    Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstra DS.
    Cancer; 2002 Jan 01; 94(1):62-77. PubMed ID: 11815961
    [Abstract] [Full Text] [Related]

  • 32. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas.
    Oda Y, Aishima S, Morimatsu K, Hayashi A, Shindo K, Fujino M, Mizuuchi Y, Hattori M, Tanaka M, Oda Y.
    Hum Pathol; 2013 Aug 01; 44(8):1487-98. PubMed ID: 23465281
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
    Michaels PJ, Brachtel EF, Bounds BC, Brugge WR, Pitman MB.
    Cancer; 2006 Jun 25; 108(3):163-73. PubMed ID: 16550572
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas.
    Kashima K, Ohike N, Mukai S, Sato M, Takahashi M, Morohoshi T.
    Hepatobiliary Pancreat Dis Int; 2008 Feb 25; 7(1):86-90. PubMed ID: 18234645
    [Abstract] [Full Text] [Related]

  • 38. Chondroitin sulfate proteoglycan CSPG4 as a novel hypoxia-sensitive marker in pancreatic tumors.
    Keleg S, Titov A, Heller A, Giese T, Tjaden C, Ahmad SS, Gaida MM, Bauer AS, Werner J, Giese NA.
    PLoS One; 2014 Feb 25; 9(6):e100178. PubMed ID: 24932730
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasia.
    Brody JR, Witkiewicz A, Williams TK, Kadkol SS, Cozzitorto J, Durkan B, Pasternack GR, Yeo CJ.
    Mod Pathol; 2007 Dec 25; 20(12):1238-44. PubMed ID: 17906614
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.